Diagnostics & Research
The Diagnostics & Research industry has a total of 47 stocks, with a combined market cap of $700.44 billion, total revenue of $169.34 billion and a weighted average PE ratio of 40.20.
Market Cap
700.44B
Revenue
169.34B
Profits
17.43B
PE Ratio
40.20
Profit Margin
10.29%
Dividend Yield
0.24%
47 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 183.56B | 5.18% | 1,903,890 | 45.20B |
| 2 | DHR | Danaher Corporation | 133.35B | 2.66% | 3,201,955 | 24.78B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 45.66B | 3.16% | 323,095 | 4.45B |
| 4 | A | Agilent Technologies, Inc. | 38.27B | 2.13% | 1,495,857 | 7.23B |
| 5 | WAT | Waters Corporation | 36.43B | 2.13% | 753,736 | 3.77B |
| 6 | NTRA | Natera, Inc. | 31.91B | 4.38% | 1,209,075 | 2.50B |
| 7 | IQV | IQVIA Holdings Inc. | 31.09B | 1.39% | 1,301,354 | 16.63B |
| 8 | ILMN | Illumina, Inc. | 24.21B | 1.24% | 1,204,490 | 4.39B |
| 9 | MTD | Mettler-Toledo International Inc. | 23.50B | 2.10% | 251,944 | 4.09B |
| 10 | DGX | Quest Diagnostics Incorporated | 22.64B | 3.71% | 572,507 | 11.28B |
| 11 | LH | Labcorp Holdings Inc. | 22.21B | 3.38% | 402,107 | 14.14B |
| 12 | GH | Guardant Health, Inc. | 17.25B | 4.18% | 1,979,773 | 1.08B |
| 13 | MEDP | Medpace Holdings, Inc. | 13.33B | 1.94% | 246,072 | 2.68B |
| 14 | ICLR | ICON Public Limited Company | 11.63B | -0.25% | 1,075,334 | 8.25B |
| 15 | RVTY | Revvity, Inc. | 11.62B | 3.82% | 997,111 | 2.90B |
| 16 | CRL | Charles River Laboratories International, Inc. | 9.15B | 1.94% | 614,023 | 4.03B |
| 17 | QGEN | Qiagen N.V. | 7.81B | 4.20% | 1,807,817 | 2.10B |
| 18 | SHC | Sotera Health Company | 4.72B | 4.45% | 2,917,739 | 1.19B |
| 19 | BLLN | BillionToOne, Inc. | 4.70B | 8.28% | 641,214 | 354.54M |
| 20 | RDNT | RadNet, Inc. | 4.42B | 3.71% | 426,578 | 2.14B |
| 21 | TWST | Twist Bioscience Corporation | 4.37B | 0.13% | 1,794,045 | 409.48M |
| 22 | VCYT | Veracyte, Inc. | 3.93B | 4.27% | 809,436 | 541.74M |
| 23 | ADPT | Adaptive Biotechnologies Corporation | 2.78B | 3.95% | 1,655,239 | 295.41M |
| 24 | GRAL | GRAIL, Inc. | 2.62B | -0.80% | 409,044 | 156.12M |
| 25 | WGS | GeneDx Holdings Corp. | 1.68B | 8.95% | 1,385,116 | 442.68M |
| 26 | NEO | NeoGenomics, Inc. | 1.49B | 4.47% | 1,698,361 | 745.97M |
| 27 | CDNA | CareDx, Inc. | 1.18B | 3.64% | 627,493 | 412.82M |
| 28 | OPK | OPKO Health, Inc. | 1.08B | 0.35% | 1,812,209 | 581.12M |
| 29 | PSNL | Personalis, Inc. | 1.02B | -2.84% | 3,751,978 | 64.52M |
| 30 | CSTL | Castle Biosciences, Inc. | 639.66M | 4.82% | 173,232 | 339.92M |
| 31 | FLGT | Fulgent Genetics, Inc. | 525.98M | 1.15% | 240,348 | 320.35M |
| 32 | MYGN | Myriad Genetics, Inc. | 428.32M | 3.30% | 953,773 | 829.00M |
| 33 | PRE | Prenetics Global Limited | 352.22M | 4.65% | 286,935 | 92.39M |
| 34 | IMDX | Insight Molecular Diagnostics Inc. | 188.24M | 1.92% | 137,859 | 1.95M |
| 35 | BDSX | Biodesix, Inc. | 154.16M | 2.01% | 20,290 | 96.10M |
| 36 | XGN | Exagen Inc. | 104.37M | 2.86% | 290,618 | 68.38M |
| 37 | BNR | Burning Rock Biotech Limited | 86.27M | -9.81% | 33,032 | 77.14M |
| 38 | PRPO | Precipio, Inc. | 41.77M | 1.74% | 24,333 | 25.83M |
| 39 | MDXH | MDxHealth SA | 29.25M | 4.29% | 369,006 | 110.97M |
| 40 | QUCY | Quantum Cyber N.V. | 25.53M | -2.86% | 1,788,414 | 537.08K |
| 41 | MBAI | Check-Cap Ltd. | 10.20M | -5.41% | 85,856 | - |
| 42 | XWEL | XWELL, Inc. | 8.78M | -14.05% | 211,874 | 28.83M |
| 43 | BIAF | bioAffinity Technologies, Inc. | 6.93M | -4.38% | 121,500 | 5.66M |
| 44 | ADVB | Advanced Biomed Inc. | 6.13M | -5.84% | 12,930 | - |
| 45 | NDRA | ENDRA Life Sciences Inc. | 5.41M | 2.11% | 17,498 | - |
| 46 | ISPC | iSpecimen Inc. | 4.20M | -1.02% | 186,609 | 1.03M |
| 47 | NOTV | Inotiv, Inc. | 3.28M | -15.30% | 25,038,495 | 507.36M |